HHS enters into strategic alliance to accelerate new antibiotic development

HHS enters into strategic alliance to accelerate new antibiotic development

Multiple drugs to combat bioterrorism threats and other life-threatening bacterial infections will be developed under a public-private partnership agreement between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and AstraZeneca, a global biopharmaceutical company.

Read more about today's announcement.